Clinical Trial Update: A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intralesional STP705 for squamous cell carcinoma in situ has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma in Situ

Drugs mentioned

• STP705

Snippet

Sponsor: Sirnaomics | Conditions: Squamous Cell Carcinoma in Situ | Phase 2 | Status: COMPLETED